Pune, India -- (SBWIRE) -- 02/21/2018 -- Global Nanomedicine Market accounted to USD 95.6 billion in 2016 growing at a CAGR of 14.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Report Consists of:

No of pages: 350

No of Figures: 60

No of Tables: 220

Global Nanomedicine Market, By Product Type (Nanomolecules, Nanoparticles (Gold nanoparticles, Silver nanoparticles, Alumina nanoparticles, Iron oxide nanoparticles, Gadolinium nanoparticles, Other metal & metal oxide nanoparticles), Liposomes, Polymer & polymer drug conjugates, Hydrogel nanoparticles, Dendrimers, Nanodevices), By Application (In-Vitro Imaging, In-Vitro Diagnostics, Vaccines), By Disease (Neurological Diseases, Cardiovascuar Diseases, Oncology, Anti-Inflammatory, Anti-Infective, Others), By Geography – Industry Trends and Forecast to 2024

Get a Free Sample Report@ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-nanomedicine-market

TABLE OF CONTENTS (TOC):

- Introduction

- Market Segmentation

- Market Overview

- Executive Summary

- Premium Insights

- By Type

- By Application

- By End User

- Geography

- Company Profiles

- Appendix

- About Data Bridge Market Research

Request for TOC Visit @ http://databridgemarketresearch.com/toc/?dbmr=global-nanomedicine-market

The medical application of nanotechnology is nanomedicine. Nanomedicine is used for prevention and treatment of various diseases.

Major Market Drivers and Restraints:


- Increasing government funding in life science research

- Increasing incidences of chronic diseases

- Increased awareness of nanomedicine

- High costs for nanomedicine based devices

- Stringent regulatory framework


Major Market Segmented:

The global nanomedicine market is segmented on the basis of raw materials, application, technology, end-user, and geography.

By product type the market for nanomedicine is segmented into nanomolecules, nanoparticles, liposomes, polymer & polymer drug conjugates, hydrogel nanoparticles, dendrimers, nanoshells, nanotubes, nanodevices.

By application the nanomedicine market is segmented into drug delivery, in-vitro imaging, therapeutics, regenerative medicine, in-vitro diagnostics, and vaccines.

On the basis of diseases the market is segmented into neurological diseases, cardiovascuar diseases, oncology, anti-inflammatory, anti-infective, others.

On the basis of geography, nanomedicine market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Major Manufacturers are:

Abbott Laboratories, CombiMatrix Corporation, GE Healthcare, Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt PLC, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Celgene Corporation, Teva Pharmaceutical Industries Ltd. among others.

Inquiry Before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-nanomedicine-market

About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com